New User? Sign Up  |  Sign In  |  Help
“Logo
 

                 LogoLogo

Question
Answer
Discover
     
Search for questions :
My Profile

philosopher

Open Questions Bookmark and Share

Is there a protein that keeps the immune system from freaking out?

The immune response to infections is a delicate balance. We need just enough action to clear away the offending bacteria or viruses, but not so much that our own bodies suffer collateral damage.

Macrophages are immune cells at the front line, detecting pathogens and kicking off an inflammatory response when needed. Understanding how macrophages determine when to go all-out and when to keep calm is key to finding new ways to strike the right balance -- particularly in cases where inflammation goes too far, such as in sepsis, colitis and other autoimmune disorders.

In a study published October 14, 2020 in the Proceedings of the National Academy of Sciences, researchers at University of California San Diego School of Medicine discovered that a molecule called Girdin, or GIV, acts as a brake on macrophages.

When the team deleted the GIV gene from mouse macrophages, the immune cells rapidly overacted to even small amounts of live bacteria or a bacterial toxin. Mice with colitis and sepsis fared worse when lacking the GIV gene in their macrophages.

The researchers also created peptides that mimic GIV, allowing them to shut down mouse macrophages on command. When treated with the GIV-mimic peptide, the mice's inflammatory response was tempered.

"When a patient dies of sepsis, he or she does not die due to the invading bacteria themselves, but from an overreaction of their immune system to the bacteria," said senior author Pradipta Ghosh, MD, professor at UC San Diego School of Medicine and Moores Cancer Center. "It's similar to what we're seeing now with dangerous 'cytokine storms' that can result from infection with the novel coronavirus SARS-CoV-2. Macrophages, and the cytokines they produce, are the body's own immune-stimulating agents and when produced in excessive amounts, they do more harm than good."

Digging deeper into the mechanism at play, Ghosh and team discovered that the GIV protein normally cozies up to a molecule called Toll-like receptor 4 (TLR4). TLR4 is stuck right through the cell membrane, with bits poking inside and outside the cell. Outside of the cell, TLR4 is like an antenna, searching for signs of invading pathogens. Inside the cell, GIV is nestled between the receptor's two "feet." When in place, GIV keeps the feet apart, and nothing happens. When GIV is removed, the TLR4 feet touch and kick off a cascade of immune-stimulating signals.

Ghosh's GIV-mimicking peptides can take the place of the protein when it's missing, keeping the feet apart and calming macrophages down.

"We were surprised at just how fluid the immune system is when it encounters a pathogen," said Ghosh, who is also director of the Institute for Network Medicine and executive director of the HUMANOID Center of Research Excellence at UC San Diego School of Medicine. "Macrophages don't need to waste time and energy producing more or less GIV protein, they can rapidly dial their response up or down simply by moving it around, and it appears that such regulation happens at the level of gene transcription."

Ghosh and team plan to investigate the factors that determine how the GIV brake remains in place when macrophages are resting or is removed to mount a response to a credible threat. To enable these studies, the Institute for Network Medicine at UC San Diego School of Medicine recently received a new $5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Ghosh shares this award with her colleagues Debashis Sahoo, PhD, assistant professor at UC San Diego School of Medicine and Jacobs School of Engineering, and Soumita Das, PhD, associate professor of pathology at UC San Diego School of Medicine.

Co-authors of the study include: Lee Swanson, Gajanan D. Katkar, Julian Tam, Rama F. Pranadinata, Yogitha Chareddy, Jane Coates, Mahitha Shree Anandachar, Vanessa Castillo, Joshua Olson, Victor Nizet, Irina Kufareva, Soumita Das, all at UC San Diego.

Story Source:

Materials provided by University of California - San Diego. Original written by Heather Buschman, PhD. Note: Content may be edited for style and length.

Journal Reference:

Lee Swanson, Gajanan D. Katkar, Julian Tam, Rama F. Pranadinata, Yogitha Chareddy, Jane Coates, Mahitha Shree Anandachar, Vanessa Castillo, Joshua Olson, Victor Nizet, Irina Kufareva, Soumita Das, and Pradipta Ghosh. TLR4 signaling and macrophage inflammatory responses are dampened by GIV/Girdin. PNAS, 2020 DOI: 10.1073/pnas.2011667117
Cite This Page:
MLA
APA
Chicago
University of California - San Diego. "Protein that keeps immune system from freaking out could form basis for new therapeutics.
See link.
https://www.sciencedaily.com/releases/2020/10/201014171320.htm

14 day(s) ago

    Comment(s) (0)
    Report
   Like  
   Email to Friends  
   Bookmark  
   Subscribe to Answer Alerts  
No comments yet !     Be the first to comment !
Answers (1)

Kravenhead
Apparently so.
That could be a significant find.
They might be able to use it to manage immune responses to infection, preventing things like sepsis.
It's estimated that 270,000 people in the US die from sepsis every year.
I hope they can develop an effective treatment using this protein.

Posted 14 day(s) ago

( 1 )
( 0 )
    Comment(s) (0)
   Report
No comments yet ! Be the first to comment on this answer !

Edit your answer. Click save, when done.
Question Title Is there a protein that keeps the immune system from freaking out?
Your Answer
  |         |                            
bold  italic  underline  strike       big  small       superscript  subscript 
  Allows to add a link.
Caption :
Link URL :
( Must starts with "http://" )
Add  |   Cancel
  Allow to insert an image. Must be among the following file types - *.jpg, *.gif, *.png & *.bmp.
Image Url :   Upload New
( Image url must always starts with " http:// " )
Width : pixels
( Must not be greater than 450px. Enter 0px for no resize )
Add  |   Cancel
  Allow to insert YouTube video. Insert the video embed code.
Embed Code :
Add  |   Cancel
Character Count ( Max. - 5000 ) : 4884
  Your comment on this question
  |         |                            
bold  italic  underline  strike       big  small       superscript  subscript 
  Allows to add a link.
Caption :
Link URL :
( Must starts with "http://" )
Add  |   Cancel
  Allow to insert an image. Must be among the following file types - *.jpg, *.gif, *.png & *.bmp.
Image Url :   Upload New
( Image url must always starts with " http:// " )
Width : pixels
( Must not be greater than 450px. Enter 0px for no resize )
Add  |   Cancel
  Allow to insert YouTube video. Insert the video embed code.
Embed Code :
Add  |   Cancel
Max Allowed : 5000 Characters Current Count : 0
  Your comment on this answer
  |         |                            
bold  italic  underline  strike       big  small       superscript  subscript 
  Allows to add a link.
Caption :
Link URL :
( Must starts with "http://" )
Add  |   Cancel
  Allow to insert an image. Must be among the following file types - *.jpg, *.gif, *.png & *.bmp.
Image Url :   Upload New
( Image url must always starts with " http:// " )
Width : pixels
( Must not be greater than 450px. Enter 0px for no resize )
Add  |   Cancel
  Allow to insert YouTube video. Insert the video embed code.
Embed Code :
Add  |   Cancel
Max Allowed : 5000 Characters Current Count : 0
Email this question link to friends
You must enter an email-address, if a name is entered and vice-versa for each friend.
Friend #1 -
Friend #2 -
Friend #3 -
Friend #4 -
Friend #5 -
Enter Security Code : *

 

Copyright ©  All rights reserved.

Contact Us   Terms of Use